|
GTF3C2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.989500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.201500E-03 |
| Normal-vs-Stage2 |
6.645900E-02 |
| Normal-vs-Stage3 |
8.28590000000462E-05 |
| Normal-vs-Stage4 |
1.848080E-04 |
| Stage1-vs-Stage2 |
7.801400E-01 |
| Stage1-vs-Stage3 |
1.508380E-01 |
| Stage1-vs-Stage4 |
2.393600E-01 |
| Stage2-vs-Stage3 |
2.847400E-01 |
| Stage2-vs-Stage4 |
3.615200E-01 |
| Stage3-vs-Stage4 |
8.116000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.414700E-04 |
| Normal-vs-AfricanAmerican |
2.397800E-01 |
| Normal-vs-Asian |
7.162000E-03 |
| Caucasian-vs-AfricanAmerican |
2.258600E-01 |
| Caucasian-vs-Asian |
8.338400E-01 |
| AfricanAmerican-vs-Asian |
3.314200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.723700E-03 |
| Normal-vs-Female |
2.562800E-04 |
| Male-vs-Female |
3.071200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.523220E-03 |
| Normal-vs-Age(41-60Yrs) |
8.604800E-04 |
| Normal-vs-Age(61-80Yrs) |
7.650000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.420460E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.102600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.686600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.013600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.596000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.378800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.841600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.715600E-01 |
| Classical-VS-Follicular |
7.574600E-01 |
| Classical-VS-Other |
5.391000E-01 |
| Classical-VS-Normal |
1.703560E-03 |
| Tall-VS-Follicular |
4.758400E-01 |
| Tall-VS-Other |
9.602800E-01 |
| Tall-VS-Normal |
2.342400E-03 |
| Follicular-VS-Other |
5.434000E-01 |
| Follicular-VS-Normal |
1.132040E-02 |
| Other-VS-Normal |
6.535900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.554500E-04 |
| Normal-vs-N1 |
2.173800E-04 |
| N0-vs-N1 |
3.748200E-01 |
|
|
